Skip to main navigation

Investor Relations

Investor Overview
Stock Information
- Stock Quote & Chart
News & Events
- News Releases
- Events
SEC Filings
Corporate Governance
Investor Resources

News Releases

News Releases

12 Oct '20

Black Diamond Therapeutics to Present Pre-Clinical Data on Lead Product Candidate BDTX-189 at the 32nd EORTC-NCI-AACR Virtual Symposium

29 Sep '20

Black Diamond Therapeutics Announces the Appointment of Biopharmaceutical Veteran Robert A. Ingram as Chairman of the Board

10 Sep '20

Black Diamond Therapeutics to Present at Morgan Stanley 18th Annual Global Healthcare Conference

08 Sep '20

Black Diamond Therapeutics Announces the Appointment of Rachel Humphrey, M.D., as Chief Medical Officer

11 Aug '20

Black Diamond Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update

05 Aug '20

Black Diamond Therapeutics to Present at Upcoming Investor Conferences

04 Aug '20

Black Diamond Therapeutics Announces the Appointment of Fang Ni as Chief Business Officer

28 Jul '20

Black Diamond Therapeutics Granted Fast Track Designation by the FDA for BDTX-189 for the Treatment of Adult Patients with a Solid Tumor Harboring an Allosteric HER2 Mutation or an EGFR or HER2 Exon 20 Insertion Mutation

16 Jun '20

Black Diamond Therapeutics to Present at the BMO 2020 Prescriptions for Success Healthcare Conference

27 May '20

Black Diamond Therapeutics to Present at the Jefferies Virtual Healthcare Conference

Pagination

First page
Previous page
Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 25

Investor Tools

Print Page
E-mail Alerts
RSS Feeds

Request E-mail Alerts

Footer Links

ABOUT US

TECHNOLOGY

PIPELINE

NEWS

CAREERS

CONTACT

© 2020 Black Diamond Therapeutics, Inc. All rights reserved.

Facebook
Twitter
LinkedIn
Google+